Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Tarsus Pharmaceuticals, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 144 Form 144 - Report of proposed sale of securities:
08/23/2023 144 Form 144 - Report of proposed sale of securities:
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "Tarsus Reports Second Quarter 2023 Financial Results and Recent Business Achievements XDEMVY™ 0.25% received FDA approval for the treatment for Demodex blepharitis"
08/02/2023 8-K Quarterly results
08/02/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/31/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/31/2023 8-K Quarterly results
07/25/2023 8-K Quarterly results
07/20/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 144 Form 144 - Report of proposed sale of securities:
07/12/2023 144 Form 144 - Report of proposed sale of securities:
06/15/2023 144 Form 144 - Report of proposed sale of securities:
06/08/2023 144 Form 144 - Report of proposed sale of securities:
06/08/2023 144 Form 144 - Report of proposed sale of securities:
06/07/2023 144 Form 144 - Report of proposed sale of securities:
06/06/2023 144 Form 144 - Report of proposed sale of securities:
05/18/2023 144 Form 144 - Report of proposed sale of securities:
05/17/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
05/17/2023 144 Form 144 - Report of proposed sale of securities:
05/10/2023 144 Form 144 - Report of proposed sale of securities:
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "Tarsus Reports First Quarter 2023 Financial Results and Recent Business Achievements Continuing to build market awareness through disease education and deploying commercial leadership in anticipation of TP-03 August 25, 2023 PDUFA"
05/05/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
05/01/2023 144 Form 144 - Report of proposed sale of securities:
04/28/2023 144 Form 144 - Report of proposed sale of securities:
04/26/2023 ARS Form ARS - Annual Report to Security Holders:
04/26/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/26/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/24/2023 8-K Quarterly results
04/21/2023 144 Form 144 - Report of proposed sale of securities:
04/20/2023 144 Form 144 - Report of proposed sale of securities:
04/19/2023 144 Form 144 - Report of proposed sale of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy